Additionally, Diagnos has engaged DS Market Solutions Inc. to maintain an orderly market for its securities, compensating them CA$5,000 monthly. The company also announced the resignation of Francis Bellido from its board of directors and audit committee. Diagnos continues to focus on leveraging AI to improve diagnostic accuracy and patient outcomes globally.
Key takeaways:
- DIAGNOS Inc. has opened its first US office in Fort Lauderdale, Florida, to expand its reach in the ophthalmic and optometry sectors.
- The company is working on obtaining US FDA certification for its AI-assisted fundus image analysis platform, which aids in diagnosing diabetic retinopathy, hypertensive retinopathy, and age-related macular degeneration.
- DIAGNOS has engaged DS Market Solutions Inc. to maintain an orderly market for its tradeable securities, with a monthly compensation of CA$5,000.
- Mr. Francis Bellido has resigned from the board of directors and as chairman of the audit committee of DIAGNOS, but remains a shareholder and continues as CEO and director of Quantum eMotion.